//分享世界日報新聞:[阿斯匹靈預防心臟病? 被曝升高出血風險!] 鏈接 https://cms.wj411.com/portal/index/newshare_weibo.jsp?id=2026687&source=13

阿斯匹靈預防心臟病? 被曝升高出血風險!

研究發現,持續服用低劑量阿斯匹靈,可以稀釋血液濃度,減少中風機會,但可能造成體內出血。(Getty Images)  編譯吳日君/綜合22日電  健康的人是否可服用阿斯匹靈預防心臟病?這個概念一直具爭議性,醫療建議也是好壞參半。不過,「美國醫學會期刊」22日公布一項科學資料顯示,服用阿斯匹靈的好處較小,並與出血機會升高風險相互抵銷。  阿斯匹靈是一種血液稀釋劑,有助於預防可能導致心臟病發作或中風的

https://cms.wj411.com/portal/index/newshare_weibo.jsp?id=2026687&source=13
Past 31 days
Total Visit: 0
There is 1 fact-checking reply to the message
重新來升等 mark this message contains true information
originally written by 重新來升等
服用阿斯匹靈是否預防心臟病目前醫界看法分歧,根據Journal of the American Medical Association的研究:「考量所有證據,阿斯匹靈對心血管帶來的益處不多。」而The Open University的Kevin McConway表示:「服用缺點是大出血風險增加,顱內和腦部或腸胃都可能發生大出血。」

References

https://tw.news.yahoo.com/吃阿斯匹靈防心臟病-研究-好處與出血風險相抵-062006380.html
吃阿斯匹靈防心臟病 研究:好處與出血風險相抵
https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/aspirin-and-heart-disease
Aspirin and Heart Disease | American Heart Association(阿斯匹靈可預防心臟病之研究)
http://www.onlinejacc.org/content/64/3/319.abstract
Aspirin Therapy in Primary Cardiovascular Disease Prevention(低劑量阿斯匹靈並無增加心血管出血率)
https://www.bmj.com/content/299/6710/1247.short
Aspirin use and chronic diseases: a cohort study of the elderly(結論:每日服用阿斯匹靈增加腎臟癌及心臟缺血的機率)

吃阿斯匹靈防心臟病 研究:好處與出血風險相抵 - Yahoo奇摩新聞

(法新社坦帕22日電) 健康者應該服用阿斯匹靈來預防心臟病嗎?這類見解頗具爭議,醫界看法也很分歧。今天公布的研究顯示,阿斯匹靈的確有好處,但都微不足道,且被出血風險升高這項壞處給抵消掉。阿斯匹靈是一種血液稀釋劑,有助預防可能引發心臟病或中風的血管栓塞,但阿斯匹靈也會升高腦部和腸胃出血的風險。根據刊登於美國醫學會期刊(Journal of the American Medical Associati

https://tw.news.yahoo.com/%E5%90%83%E9%98%BF%E6%96%AF%E5%8C%B9%E9%9D%88%E9%98%B2%E5%BF%83%E8%87%9F%E7%97%85-%E7%A0%94%E7%A9%B6-%E5%A5%BD%E8%99%95%E8%88%87%E5%87%BA%E8%A1%80%E9%A2%A8%E9%9A%AA%E7%9B%B8%E6%8A%B5-062006380.html

Aspirin Therapy in Primary Cardiovascular Disease Prevention

Journal of the American College of Cardiology , Felicita Andreotti, Jurriën M. ten Berg, Marco Cattaneo, Sergio Coccheri, Roberto Marchioli, João Morais, Freek W.A. V

http://www.onlinejacc.org/content/64/3/319.abstract

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙